Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Natalizi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
In Vivo (Athens, Greece)|August 26, 2024
Gastric Cancer in the Lesser and Greater Curvature: A Comparative Analysis from a Single Western CenterNicola Natalizi, Luigina Graziosi, Annibale Donini
Journal of Personalized Medicine|June 28, 2023
Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. <i>J. Pers. Med.</i> 2023, <i>13</i>, 553Luigina Graziosi, Nicola Natalizi, Annibale Donini
Updates in Surgery|June 22, 2023
Evaluation of peritoneal Carcinoembryonic Antigen as a survival prognostic factor in gastric cancer patients: a single western center experienceNicola Natalizi, Elisabetta Marino, Luigina Graziosi, et al.
Journal of Personalized Medicine|July 29, 2023
Prognostic Survival Significance of Signet Ring Cell (SRC) Gastric Cancer: Retrospective Analysis from a Single Western CenterLuigina Graziosi, Elisabetta Marino, Nicola Natalizi, et al.
Updates in Surgery|August 19, 2025
Survival prognostic impact of post-surgical complications in gastric cancer patients after neoadjuvant chemotherapy: a single western center analysisNicola Natalizi, Luigina Graziosi, Fabiola Di Schiena, et al.
Dermatology Reports|January 10, 2022
A rare case of polypoid primary anorectal melanoma with subsequent giant stomach metastasis: A gastrointestinal involvement of both primary and metastatic mucosal melanomaVincenzo De Giorgi, Federica Scarfì, Carlo Boselli, et al.
Biochemistry and Biophysics Reports|June 8, 2026
The Farnesoid X receptor-bile acid axis contributes to immune evasion in gastric cancer and its inhibition enhances efficacy of anti-PD-L1 therapyCristina Di Giorgio, Michele Biagioli, Silvia Marchianò, et al.
Translational Oncology|June 8, 2026
Pharmacological inhibition of LIF signaling reverses PD-L1-mediated immune suppression in gastric cancerCristina Di Giorgio, Silvia Marchianò, Michele Biagioli, et al.
Cells|February 26, 2026
Tumor-Derived LIF Promotes GDF15-Driven Cachexia and Adverse Outcomes in Gastric CancerCristina Di Giorgio, Nicola Natalizi, Maria Rosaria Sette, et al.
Biochemical Pharmacology|March 17, 2024
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesisCristina Di Giorgio, Elva Morretta, Antonio Lupia, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
In Vivo (Athens, Greece)|August 26, 2024
Gastric Cancer in the Lesser and Greater Curvature: A Comparative Analysis from a Single Western CenterNicola Natalizi, Luigina Graziosi, Annibale Donini
Journal of Personalized Medicine|June 28, 2023
Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. <i>J. Pers. Med.</i> 2023, <i>13</i>, 553Luigina Graziosi, Nicola Natalizi, Annibale Donini
Updates in Surgery|June 22, 2023
Evaluation of peritoneal Carcinoembryonic Antigen as a survival prognostic factor in gastric cancer patients: a single western center experienceNicola Natalizi, Elisabetta Marino, Luigina Graziosi, et al.
Journal of Personalized Medicine|July 29, 2023
Prognostic Survival Significance of Signet Ring Cell (SRC) Gastric Cancer: Retrospective Analysis from a Single Western CenterLuigina Graziosi, Elisabetta Marino, Nicola Natalizi, et al.
Updates in Surgery|August 19, 2025
Survival prognostic impact of post-surgical complications in gastric cancer patients after neoadjuvant chemotherapy: a single western center analysisNicola Natalizi, Luigina Graziosi, Fabiola Di Schiena, et al.
Dermatology Reports|January 10, 2022
A rare case of polypoid primary anorectal melanoma with subsequent giant stomach metastasis: A gastrointestinal involvement of both primary and metastatic mucosal melanomaVincenzo De Giorgi, Federica Scarfì, Carlo Boselli, et al.
Biochemistry and Biophysics Reports|June 8, 2026
The Farnesoid X receptor-bile acid axis contributes to immune evasion in gastric cancer and its inhibition enhances efficacy of anti-PD-L1 therapyCristina Di Giorgio, Michele Biagioli, Silvia Marchianò, et al.
Translational Oncology|June 8, 2026
Pharmacological inhibition of LIF signaling reverses PD-L1-mediated immune suppression in gastric cancerCristina Di Giorgio, Silvia Marchianò, Michele Biagioli, et al.
Cells|February 26, 2026
Tumor-Derived LIF Promotes GDF15-Driven Cachexia and Adverse Outcomes in Gastric CancerCristina Di Giorgio, Nicola Natalizi, Maria Rosaria Sette, et al.
Biochemical Pharmacology|March 17, 2024
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesisCristina Di Giorgio, Elva Morretta, Antonio Lupia, et al.
Pageof 2